NeuroSense Therapeutics Ltd. Gains 68.83%
Mon, Feb 28, 2022 at 05:30 PM
NeuroSense Therapeutics Ltd. (NRSN:NASDAQ) shot up at $2.6, a gain of 68.8%. The stock got featured on our News Catalysts scanner on Thu, Feb 24, 2022 at 10:46 AM in the 'MISCELLANEOUS' category. From Mon, Feb 14, 2022, the stock recorded 37.50% Up Days and 11.11% Green Days
About NeuroSense Therapeutics Ltd. (NRSN:NASDAQ)
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these...
Top 10 Gainers:
- Mullen Automotive Inc. (MULN:NASDAQ), 145.64%
- NeuroSense Therapeutics Ltd. (NRSN:NASDAQ), 68.83%
- Document Security Systems, Inc. (DSS:NYSEMKT), 47.24%
- China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), 45.33%
- Renewable Energy Group, Inc. (REGI:NASDAQ), 40.38%
- IntriCon Corporation (IIN:NASDAQ), 37.37%
- Avenue Therapeutics, Inc. (ATXI:NASDAQ), 35.96%
- Everbridge, Inc. (EVBG:NASDAQ), 29.11%
- First Horizon National Corporation (FHN:NYSE), 28.66%
- G Medical Innovations Holdings Ltd. (GMVD:NASDAQ), 27.91%